Regulatory approvable therapies


Osteoarthritis is a debilitating disease and the major source of opioid crisis.

Jointechlabs is utilizing its technological platform for development of interventional (non surgical) treatment of osteoarthritis (OA) at various stages. Our goal is preventing the progress of OA at early stages as well as offering injectable treatment for late stages, replacing the majority of surgical interventions by in office procedure.

Our treatment is based on extensive research of stem cells mechanism of action and proprietary technology for cell extraction, encapsulation and delivery.

3D Bioprinting of autologous adipose tissue for wound healing

Critical skin wounds are a major cost for the health sector and lead to immense suffering for the patients. One way to facilitate healing of these wounds is through autologous autologous adipose tissue transplants. However, the implanted tissue needs to be vascularized or it will suffer from necrosis. To combat this, Stromal vascular fraction (SVF), which is isolated from fat, can be utilized as it has been shown to promote both vascularization and the wound healing process. We develop a method for 3D printing of SVF enriched fat graft constructs for in situ vascularization and facilitation of deep wound healing.